MDxHealth SA (MDXH) – Strategy, SWOT and Corporate Finance Report
- Pages: 50
- Published: July 2023
- Report Code: MLME82376FSA
MDxHealth SA (MDXH) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment, and the personalized treatment of patients. The company’s product portfolio includes ConfirmMDx, an epigenetic assay that detects the epigenetic effect of cancer; SelectMDx, a liquid biopsy assay for prostate cancer. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform. It also offers biomarker development services to many pharmaceutical companies. MDxHealth markets its products through sales forces, partnerships and distributors. The company has operations in the Netherlands, Belgium, and the US. MDxHealth is headquartered in Herstal, Liege, Belgium.
Scope
• Detailed information on MDxHealth SA required for business and competitor intelligence needs
• A study of the major internal and external factors affecting MDxHealth SA in the form of a SWOT analysis
• An in-depth view of the business model of MDxHealth SA including a breakdown and examination of key business segments
• News about MDxHealth SA, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of MDxHealth SA and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess MDxHealth SA as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on MDxHealth SAs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Agendia NV
Myriad Genetics Inc
Hologic Ltd
Epigenomics AG
Genomic Health Inc
OPKO Health Inc
Beckman Coulter Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.